Review



primary antibodies antiadenomatous polyposis coli clone cc1  (Millipore)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Millipore primary antibodies antiadenomatous polyposis coli clone cc1
    Primary Antibodies Antiadenomatous Polyposis Coli Clone Cc1, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibodies antiadenomatous polyposis coli clone cc1/product/Millipore
    Average 90 stars, based on 1 article reviews
    primary antibodies antiadenomatous polyposis coli clone cc1 - by Bioz Stars, 2026-03
    90/100 stars

    Images



    Similar Products

    90
    Millipore primary antibodies antiadenomatous polyposis coli clone cc1
    Primary Antibodies Antiadenomatous Polyposis Coli Clone Cc1, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibodies antiadenomatous polyposis coli clone cc1/product/Millipore
    Average 90 stars, based on 1 article reviews
    primary antibodies antiadenomatous polyposis coli clone cc1 - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    GeneTex primary cc1 antibody gtx16794
    Primary Cc1 Antibody Gtx16794, supplied by GeneTex, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary cc1 antibody gtx16794/product/GeneTex
    Average 90 stars, based on 1 article reviews
    primary cc1 antibody gtx16794 - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Merck KGaA primary antibodies against mouse cc1 #op80-100ug
    Primary Antibodies Against Mouse Cc1 #Op80 100ug, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibodies against mouse cc1 #op80-100ug/product/Merck KGaA
    Average 90 stars, based on 1 article reviews
    primary antibodies against mouse cc1 #op80-100ug - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Affinity Biosciences primary antibodies against cc1 af4022
    Primary Antibodies Against Cc1 Af4022, supplied by Affinity Biosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibodies against cc1 af4022/product/Affinity Biosciences
    Average 90 stars, based on 1 article reviews
    primary antibodies against cc1 af4022 - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Millipore primary antibodies cc1
    Primary Antibodies Cc1, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibodies cc1/product/Millipore
    Average 90 stars, based on 1 article reviews
    primary antibodies cc1 - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Millipore primary mouse monoclonal antibody against cc1
    Primary Mouse Monoclonal Antibody Against Cc1, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary mouse monoclonal antibody against cc1/product/Millipore
    Average 90 stars, based on 1 article reviews
    primary mouse monoclonal antibody against cc1 - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Millipore primary antibody mouse anti-cc1 apc-7
    Primary Antibody Mouse Anti Cc1 Apc 7, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibody mouse anti-cc1 apc-7/product/Millipore
    Average 90 stars, based on 1 article reviews
    primary antibody mouse anti-cc1 apc-7 - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Millipore primary antibodies to apc (cc1)
    Enhanced oligodendrogenesis in the spinal cord gray matter of adult ALS mice. ( a ) Protocol used to trace the fate of NG2 + cells in PDGFαR-CreER;Z/EG ± SOD1 (G93A) mice. Cohorts of NG2 + cells were labeled with EGFP by 4HT injection at P30 or P60 then analyzed at different ages. ( b ) Fluorescence images showing EGFP + NG2 + cell progeny in the ventral horn of the spinal cord in control or SOD1 (G93A) mice 60 days after 4HT administration at P30 (P30+60). Scale bar: 100 μm. ( c – e ) Maps of the location of adult born oligodendrocytes generated from NG2 + cells in the spinal cord of control (blue circles) or SOD1 (G93A) mice (red circles), from P60 to P75 ( c ), from P60 to P90 ( d ), or from P60 to P120 (or end stage for ALS mice) ( e ). Oligodendrocytes (EGFP + <t>CC1</t> + ) in four randomly sampled lumbar spinal cord sections from each group (from 3–4 mice) are shown. ( f – h ) Graphs showing the density of newly generated EGFP + CC1 + oligodendrocytes in different regions of the adult spinal cord from control (white bars) and SOD1 (G93A) mice (gray bars). Mean + s.e.m. ( n = 9 sections from 3 mice per group) * P < 0.05, ** P < 0.001, *** P < 0.0005, unpaired Student’s t test. i ) Graph showing the overall density of oligodendrocytes (Olig2 + CC1 + ) in different regions of the spinal cord of P120 and end stage SOD1 (G93A) mice. Mean + s.e.m. ( n = 12 sections per group from 4 mice per group) N.S., non-significant, one-way ANOVA with Tukey test.
    Primary Antibodies To Apc (Cc1), supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibodies to apc (cc1)/product/Millipore
    Average 90 stars, based on 1 article reviews
    primary antibodies to apc (cc1) - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Millipore primary antibody cc1
    Enhanced oligodendrogenesis in the spinal cord gray matter of adult ALS mice. ( a ) Protocol used to trace the fate of NG2 + cells in PDGFαR-CreER;Z/EG ± SOD1 (G93A) mice. Cohorts of NG2 + cells were labeled with EGFP by 4HT injection at P30 or P60 then analyzed at different ages. ( b ) Fluorescence images showing EGFP + NG2 + cell progeny in the ventral horn of the spinal cord in control or SOD1 (G93A) mice 60 days after 4HT administration at P30 (P30+60). Scale bar: 100 μm. ( c – e ) Maps of the location of adult born oligodendrocytes generated from NG2 + cells in the spinal cord of control (blue circles) or SOD1 (G93A) mice (red circles), from P60 to P75 ( c ), from P60 to P90 ( d ), or from P60 to P120 (or end stage for ALS mice) ( e ). Oligodendrocytes (EGFP + <t>CC1</t> + ) in four randomly sampled lumbar spinal cord sections from each group (from 3–4 mice) are shown. ( f – h ) Graphs showing the density of newly generated EGFP + CC1 + oligodendrocytes in different regions of the adult spinal cord from control (white bars) and SOD1 (G93A) mice (gray bars). Mean + s.e.m. ( n = 9 sections from 3 mice per group) * P < 0.05, ** P < 0.001, *** P < 0.0005, unpaired Student’s t test. i ) Graph showing the overall density of oligodendrocytes (Olig2 + CC1 + ) in different regions of the spinal cord of P120 and end stage SOD1 (G93A) mice. Mean + s.e.m. ( n = 12 sections per group from 4 mice per group) N.S., non-significant, one-way ANOVA with Tukey test.
    Primary Antibody Cc1, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibody cc1/product/Millipore
    Average 90 stars, based on 1 article reviews
    primary antibody cc1 - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    Image Search Results


    Enhanced oligodendrogenesis in the spinal cord gray matter of adult ALS mice. ( a ) Protocol used to trace the fate of NG2 + cells in PDGFαR-CreER;Z/EG ± SOD1 (G93A) mice. Cohorts of NG2 + cells were labeled with EGFP by 4HT injection at P30 or P60 then analyzed at different ages. ( b ) Fluorescence images showing EGFP + NG2 + cell progeny in the ventral horn of the spinal cord in control or SOD1 (G93A) mice 60 days after 4HT administration at P30 (P30+60). Scale bar: 100 μm. ( c – e ) Maps of the location of adult born oligodendrocytes generated from NG2 + cells in the spinal cord of control (blue circles) or SOD1 (G93A) mice (red circles), from P60 to P75 ( c ), from P60 to P90 ( d ), or from P60 to P120 (or end stage for ALS mice) ( e ). Oligodendrocytes (EGFP + CC1 + ) in four randomly sampled lumbar spinal cord sections from each group (from 3–4 mice) are shown. ( f – h ) Graphs showing the density of newly generated EGFP + CC1 + oligodendrocytes in different regions of the adult spinal cord from control (white bars) and SOD1 (G93A) mice (gray bars). Mean + s.e.m. ( n = 9 sections from 3 mice per group) * P < 0.05, ** P < 0.001, *** P < 0.0005, unpaired Student’s t test. i ) Graph showing the overall density of oligodendrocytes (Olig2 + CC1 + ) in different regions of the spinal cord of P120 and end stage SOD1 (G93A) mice. Mean + s.e.m. ( n = 12 sections per group from 4 mice per group) N.S., non-significant, one-way ANOVA with Tukey test.

    Journal: Nature neuroscience

    Article Title: Degeneration and impaired regeneration of gray matter oligodendrocytes in amyotrophic lateral sclerosis

    doi: 10.1038/nn.3357

    Figure Lengend Snippet: Enhanced oligodendrogenesis in the spinal cord gray matter of adult ALS mice. ( a ) Protocol used to trace the fate of NG2 + cells in PDGFαR-CreER;Z/EG ± SOD1 (G93A) mice. Cohorts of NG2 + cells were labeled with EGFP by 4HT injection at P30 or P60 then analyzed at different ages. ( b ) Fluorescence images showing EGFP + NG2 + cell progeny in the ventral horn of the spinal cord in control or SOD1 (G93A) mice 60 days after 4HT administration at P30 (P30+60). Scale bar: 100 μm. ( c – e ) Maps of the location of adult born oligodendrocytes generated from NG2 + cells in the spinal cord of control (blue circles) or SOD1 (G93A) mice (red circles), from P60 to P75 ( c ), from P60 to P90 ( d ), or from P60 to P120 (or end stage for ALS mice) ( e ). Oligodendrocytes (EGFP + CC1 + ) in four randomly sampled lumbar spinal cord sections from each group (from 3–4 mice) are shown. ( f – h ) Graphs showing the density of newly generated EGFP + CC1 + oligodendrocytes in different regions of the adult spinal cord from control (white bars) and SOD1 (G93A) mice (gray bars). Mean + s.e.m. ( n = 9 sections from 3 mice per group) * P < 0.05, ** P < 0.001, *** P < 0.0005, unpaired Student’s t test. i ) Graph showing the overall density of oligodendrocytes (Olig2 + CC1 + ) in different regions of the spinal cord of P120 and end stage SOD1 (G93A) mice. Mean + s.e.m. ( n = 12 sections per group from 4 mice per group) N.S., non-significant, one-way ANOVA with Tukey test.

    Article Snippet: We used primary antibodies to APC (CC1) (mouse, Calbiochem, 1:50), BrdU (rat, Accurate, 1:500), Caspase-3 (rabbit, Cell Signaling, 1:500), ChAT (goat, Millipore, 1:300), EGFP (goat, Frontier Institute, 1:500), EGFP (rabbit, a gift from Dr. Richard Huganir, Johns Hopkins University, 1:500), GFAP (mouse, NeuroMab, 1:500), GFAP (rabbit, DAKO, 1:1,000), Iba1 (rabbit, Wako, 1:1,000), Ki67 (rabbit, Abcam, 1:500), NG2 (guinea pig, 1:3,600), Olig2 (guinea pig, a gift from Dr. Ben Novitch, UCLA, 1:20,000), Olig2 (rabbit, Millipore, 1:500), PDGFαR (rabbit, a gift from Dr. William Stallcup, Burnham Institute, 1:500), SMI32 (mouse, Covance, 1:1,000), and hSOD1 (rabbit, 1:70).

    Techniques: Labeling, Injection, Fluorescence, Control, Generated

    Progressive degeneration of oligodendrocytes in the spinal cord ventral gray matter of ALS mice. ( a ) Protocol used to track the fate of early-born oligodendrocytes. Littermate control and SOD1 (G93A) expressing PLP-CreER;ROSA26-EYFP mice received 4HT (2 mg) at P35 and were analyzed at P40, P50, P90 and P120 (or end stage for ALS mice). ( b ) Schematic showing the rationale and possible outcomes of oligodendrocyte fate analysis. ( c,d ) Plot of the number of EYFP + oligodendrocytes (CC1 + Olig2 + ) in ventral gray mater (GM) ( c ) and ventral white matter (WM) ( d ) of PLP-CreER;ROSA26-EYFP ± SOD1 (G93A) mice, expressed relative to the number observed at P35+15 (P50). Note that control group had additional time point (P35+10). Means ± s.e.m. ( n = 9 sections from 3 mice per each time point of each group). * P < 0.05, ** P < 0.001, *** P < 0.0005. Unpaired Student’s t -test was used to compare mean values between control and SOD1 (G93A) mice at each time point. One-way ANOVA with Tukey test was used for age-dependent relative changes in EYFP + oligodendrocytes in each group. ( e ) Confocal images showing the density and morphology of EYFP + (stained with anti-EGFP antibody) CC1 + Olig2 + spinal cord oligodendrocytes (yellow arrows) in ventral gray matter at P120 (control) or at end stage SOD1 (G93A) mice. Scale bars: 20μm.

    Journal: Nature neuroscience

    Article Title: Degeneration and impaired regeneration of gray matter oligodendrocytes in amyotrophic lateral sclerosis

    doi: 10.1038/nn.3357

    Figure Lengend Snippet: Progressive degeneration of oligodendrocytes in the spinal cord ventral gray matter of ALS mice. ( a ) Protocol used to track the fate of early-born oligodendrocytes. Littermate control and SOD1 (G93A) expressing PLP-CreER;ROSA26-EYFP mice received 4HT (2 mg) at P35 and were analyzed at P40, P50, P90 and P120 (or end stage for ALS mice). ( b ) Schematic showing the rationale and possible outcomes of oligodendrocyte fate analysis. ( c,d ) Plot of the number of EYFP + oligodendrocytes (CC1 + Olig2 + ) in ventral gray mater (GM) ( c ) and ventral white matter (WM) ( d ) of PLP-CreER;ROSA26-EYFP ± SOD1 (G93A) mice, expressed relative to the number observed at P35+15 (P50). Note that control group had additional time point (P35+10). Means ± s.e.m. ( n = 9 sections from 3 mice per each time point of each group). * P < 0.05, ** P < 0.001, *** P < 0.0005. Unpaired Student’s t -test was used to compare mean values between control and SOD1 (G93A) mice at each time point. One-way ANOVA with Tukey test was used for age-dependent relative changes in EYFP + oligodendrocytes in each group. ( e ) Confocal images showing the density and morphology of EYFP + (stained with anti-EGFP antibody) CC1 + Olig2 + spinal cord oligodendrocytes (yellow arrows) in ventral gray matter at P120 (control) or at end stage SOD1 (G93A) mice. Scale bars: 20μm.

    Article Snippet: We used primary antibodies to APC (CC1) (mouse, Calbiochem, 1:50), BrdU (rat, Accurate, 1:500), Caspase-3 (rabbit, Cell Signaling, 1:500), ChAT (goat, Millipore, 1:300), EGFP (goat, Frontier Institute, 1:500), EGFP (rabbit, a gift from Dr. Richard Huganir, Johns Hopkins University, 1:500), GFAP (mouse, NeuroMab, 1:500), GFAP (rabbit, DAKO, 1:1,000), Iba1 (rabbit, Wako, 1:1,000), Ki67 (rabbit, Abcam, 1:500), NG2 (guinea pig, 1:3,600), Olig2 (guinea pig, a gift from Dr. Ben Novitch, UCLA, 1:20,000), Olig2 (rabbit, Millipore, 1:500), PDGFαR (rabbit, a gift from Dr. William Stallcup, Burnham Institute, 1:500), SMI32 (mouse, Covance, 1:1,000), and hSOD1 (rabbit, 1:70).

    Techniques: Control, Expressing, Staining

    Early disruption of oligodendrocyte structure in the spinal cord of ALS mice. ( a,b ) Confocal images of EGFP + structures in the ventral spinal cord gray matter from control MOBP-EGFP (P120) and MOBP-EGFP;SOD1 (G93A) mice (end stage). Panels in ( b ) show regions highlighted by white squares in ( a ). Arrowheads indicate large EGFP + structures that were Olig2 − and CC1 − . Scale bars: 20 μm. ( c ) Measured volume of Olig2 − EGFP + fragments in each 250,000 μm 3 imaged volume. Mean + s.e.m. ( n = 6 – 9 sections from 3 mice per group) ** P = 1.5 × 10 −5 , *** P = 8 × 10 −6 , unpaired Student’s t -test.

    Journal: Nature neuroscience

    Article Title: Degeneration and impaired regeneration of gray matter oligodendrocytes in amyotrophic lateral sclerosis

    doi: 10.1038/nn.3357

    Figure Lengend Snippet: Early disruption of oligodendrocyte structure in the spinal cord of ALS mice. ( a,b ) Confocal images of EGFP + structures in the ventral spinal cord gray matter from control MOBP-EGFP (P120) and MOBP-EGFP;SOD1 (G93A) mice (end stage). Panels in ( b ) show regions highlighted by white squares in ( a ). Arrowheads indicate large EGFP + structures that were Olig2 − and CC1 − . Scale bars: 20 μm. ( c ) Measured volume of Olig2 − EGFP + fragments in each 250,000 μm 3 imaged volume. Mean + s.e.m. ( n = 6 – 9 sections from 3 mice per group) ** P = 1.5 × 10 −5 , *** P = 8 × 10 −6 , unpaired Student’s t -test.

    Article Snippet: We used primary antibodies to APC (CC1) (mouse, Calbiochem, 1:50), BrdU (rat, Accurate, 1:500), Caspase-3 (rabbit, Cell Signaling, 1:500), ChAT (goat, Millipore, 1:300), EGFP (goat, Frontier Institute, 1:500), EGFP (rabbit, a gift from Dr. Richard Huganir, Johns Hopkins University, 1:500), GFAP (mouse, NeuroMab, 1:500), GFAP (rabbit, DAKO, 1:1,000), Iba1 (rabbit, Wako, 1:1,000), Ki67 (rabbit, Abcam, 1:500), NG2 (guinea pig, 1:3,600), Olig2 (guinea pig, a gift from Dr. Ben Novitch, UCLA, 1:20,000), Olig2 (rabbit, Millipore, 1:500), PDGFαR (rabbit, a gift from Dr. William Stallcup, Burnham Institute, 1:500), SMI32 (mouse, Covance, 1:1,000), and hSOD1 (rabbit, 1:70).

    Techniques: Disruption, Control